Sograzepide结构式
|
常用名 | Sograzepide | 英文名 | Sograzepide |
|---|---|---|---|---|
| CAS号 | 155488-25-8 | 分子量 | 498.57600 | |
| 密度 | 1.25g/cm3 | 沸点 | 723.049ºC at 760 mmHg | |
| 分子式 | C28H30N6O3 | 熔点 | N/A | |
| MSDS | N/A | 闪点 | 391.086ºC |
Sograzepide用途Sograzepide (Netazepide;YF476) 是一种胃泌素/缩胆囊素2受体 (gastrin/cholecystokinin 2 receptor (CCK2)) 拮抗剂。 |
| 中文名 | N-[(3R)-1-(3,3-二甲基-2-氧代丁基)-2,3-二氢-2-氧代-5-(2-吡啶基)-1H-1,4-苯并二氮杂卓-3-基]-N’-[3-(甲基氨基)苯基]脲 |
|---|---|
| 英文名 | 1-[(3R)-1-(3,3-dimethyl-2-oxobutyl)-2-oxo-5-pyridin-2-yl-3H-1,4-benzodiazepin-3-yl]-3-[3-(methylamino)phenyl]urea |
| 英文别名 | 更多 |
| 描述 | Sograzepide (Netazepide;YF476) 是一种胃泌素/缩胆囊素2受体 (gastrin/cholecystokinin 2 receptor (CCK2)) 拮抗剂。 |
|---|---|
| 相关类别 | |
| 靶点实验 |
Gastrin/cholecystokinin 2 receptor (CCK2)[1] |
| 参考文献 |
| 密度 | 1.25g/cm3 |
|---|---|
| 沸点 | 723.049ºC at 760 mmHg |
| 分子式 | C28H30N6O3 |
| 分子量 | 498.57600 |
| 闪点 | 391.086ºC |
| 精确质量 | 498.23800 |
| PSA | 119.28000 |
| LogP | 4.04840 |
| InChIKey | YDZYKNJZCVIKPP-VWLOTQADSA-N |
| SMILES | CNc1cccc(NC(=O)NC2N=C(c3ccccn3)c3ccccc3N(CC(=O)C(C)(C)C)C2=O)c1 |
| 储存条件 | 2-8℃ |
|
~%
Sograzepide 155488-25-8 |
| 文献:Journal of Medicinal Chemistry, , vol. 40, # 3 p. 331 - 341 |
|
~%
Sograzepide 155488-25-8 |
| 文献:Journal of Medicinal Chemistry, , vol. 40, # 3 p. 331 - 341 |
|
~%
Sograzepide 155488-25-8 |
| 文献:Journal of Medicinal Chemistry, , vol. 40, # 3 p. 331 - 341 |
|
~%
Sograzepide 155488-25-8 |
| 文献:Journal of Medicinal Chemistry, , vol. 40, # 3 p. 331 - 341 |
|
~%
Sograzepide 155488-25-8 |
| 文献:Journal of Medicinal Chemistry, , vol. 40, # 3 p. 331 - 341 |
|
~%
Sograzepide 155488-25-8 |
| 文献:Journal of Medicinal Chemistry, , vol. 40, # 3 p. 331 - 341 |
|
~%
Sograzepide 155488-25-8 |
| 文献:Journal of Medicinal Chemistry, , vol. 40, # 3 p. 331 - 341 |
|
~%
Sograzepide 155488-25-8 |
| 文献:Journal of Medicinal Chemistry, , vol. 40, # 3 p. 331 - 341 |
|
~%
Sograzepide 155488-25-8 |
| 文献:Journal of Medicinal Chemistry, , vol. 40, # 3 p. 331 - 341 |
| UNII-HOU4I0G29C |
| YF-476 |
| Sograzepide |